Latest Breaking News On - Caseyc kopczynski - Page 1 : comparemela.com

Markets Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI – Research Report) today and set a price target of $26.00. The company’s shares closed last Tuesday at $17.66. According to TipRanks.com, Belanger is a 4-star analyst with an average return of 8.8% and a 49.5% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, KalVista Pharmaceuticals, and Collegium Pharmaceutical. Aerie Pharma has an analyst consensus of Strong Buy, with a price target consensus of $27.25, implying a 47.6% upside from current levels. In a report issued on April 15, Oppenheimer also maintained a Buy rating on the stock with a $26.00 price target.

Serge belangerCaseyc kopczynskiDavidl epsteinEricj tooneAmphastar pharmaceuticalsAerie pharmaceuticals incKalvista pharmaceuticalsAerie pharmaResearch reportStrong buyசெர்ஜ் பேலங்கேர்ஏறியே மருந்துகள் இன்க்ஏறியே பார்மாஆராய்ச்சி அறிக்கைவலுவான வாங்க